Timing is everything: new study pinpoints best moment to check tumor DNA after lymphoma treatment
NCT ID NCT06141772
First seen Jan 04, 2026 · Last updated May 14, 2026 · Updated 23 times
Summary
This study looked at how levels of circulating tumor DNA (ctDNA) change in the hours after the first dose of chemotherapy for diffuse large B-cell lymphoma. Researchers wanted to find the best time to take blood samples for follow-up testing. The study involved 24 adults with this type of lymphoma who were hospitalized for their first treatment cycle.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Henri Becquerel
Rouen, 76000, France
Conditions
Explore the condition pages connected to this study.